- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04224129
Characterization and Causative Factors of Negative Dysphotopsia (NDys)
January 7, 2020 updated by: Prim. Prof. Dr. Oliver Findl, MBA, Vienna Institute for Research in Ocular Surgery
Defining and Quantifying Negative Dysphotopsia Characterization and Causative Factors of Negative Dysphotopsia
The present study is designed as an exploratory study, seeking to investigate the correlation of patient complaints to subjective or objective measurement methods.
Better understanding of causative factors of negative dysphotopsia will improve detection and maybe prediction of this optical phenomenon.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
10
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, A-1140
- Recruiting
- Hanusch-Krankenhaus
-
Contact:
- Oliver Findl, MD, MBA
- Phone Number: +431 910 21 84611
- Email: oliver@findl.at
-
Principal Investigator:
- Oliver Findl, MD, MBA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
10 patients after cataract extraction, suffering from negative dysphotopsia
Description
Inclusion Criteria:
- Pseudophakic
- Recurrently and persistently reporting about negative dysphotopsia
- Age 21 and older
- written informed consent prior to entering the study
Exclusion Criteria:
- Relevant ophthalmic diseases such as: glaucoma, (previous) traumatic cataract, corneal scars, age-related macular degeneration and other pathologies resulting in visual field defects
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of factors or a combination thereof that may cause negative dysphotopsia
Time Frame: 2 hours
|
Biometry, Anamnesis, visual field, psychological questionnaires, wavefront aberrometry will be used to analyse if a factor causative for negative dysphotopsia can be detected
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Method to standardize characterization of negative dysphotopsia
Time Frame: 20 minutes
|
New approaches like Goldmann visual field are used to try to picture negative dysphotopsias and patients will also be asked to draw the "dark shadows"
|
20 minutes
|
|
Correlation between eye biometry, patient complaints and psychophysics
Time Frame: 30 minutes
|
Eye biometry will be measured using IOL Master 700, patient complaints will be asked during an patient-doctor interview, and psychophysics will be assessed using a psychological questionnaire
|
30 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (ANTICIPATED)
December 1, 2020
Study Completion (ANTICIPATED)
May 1, 2021
Study Registration Dates
First Submitted
April 11, 2017
First Submitted That Met QC Criteria
January 7, 2020
First Posted (ACTUAL)
January 13, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 13, 2020
Last Update Submitted That Met QC Criteria
January 7, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NDys
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pseudoaphakia
-
Sun Yat-sen UniversityNational Natural Science Foundation of ChinaCompleted
-
Haag Streit USACompletedPseudoaphakiaUnited States